Document Detail

Mesenchymal stem cell therapy in skin: why and what for?
MedLine Citation:
PMID:  23614735     Owner:  NLM     Status:  In-Data-Review    
In recent years, few stem cells have gained as much clinical notoriety as mesenchymal stem cells. Indeed, MSCs are already in use for a range of systemic inflammatory and autoimmune conditions that also affect the skin, such as acute and chronic graft versus host disease or lupus erythematosus. Most interestingly, these cells are able to improve skin wound healing in multiple preclinical models and few patient series. An additional potential of these cells is the delivery of missing structural elements in skin inherited disorders. However, we here contend that MSCs are not appropriate for cell replacement therapies in the context of wound healing. Indeed, engraftment of cells in the dermis is poor in the absence of irradiation and the observed effects seem mainly due to paracrine factors. In this viewpoint, we favour the hypothesis of a replete niche and competition with resident mesenchymal populations in the dermis not allowing the engraftment of newly delivered MSCs. Consequently, we propose that the benefit of MSCs may be at least in part reproduced by the growth factors or immunomodulatory molecules that they produce. In any case, the rapid progress in this field has allowed the emergence of important questions in skin biology that need to be addressed in parallel with the predictable future use of MSCs in the clinic.
Kiarash Khosrotehrani
Related Documents :
24061975 - Mesenchymal stem cells derived from vertebrae (vmscs) show best biological properties.
24506885 - Histone variants enriched in oocytes enhance reprogramming to induced pluripotent stem ...
23041435 - The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem c...
23770975 - The human natural killer cytotoxic cell line nk-92, once armed with a murine cd16 recep...
20827525 - Microrna detection in bone marrow cells by lna-fish.
17472985 - Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Experimental dermatology     Volume:  22     ISSN:  1600-0625     ISO Abbreviation:  Exp. Dermatol.     Publication Date:  2013 May 
Date Detail:
Created Date:  2013-04-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9301549     Medline TA:  Exp Dermatol     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  307-10     Citation Subset:  IM    
Copyright Information:
© 2013 John Wiley & Sons A/S.
UQ Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Carbon Encapsulated Fe3O4 Nanoparticles as a High-Rate Lithium Ion Battery Anode Material.
Next Document:  Potential role of FoxO1 and mTORC1 in the pathogenesis of Western diet-induced acne.